The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

Abstract: Traditional approaches for transmission system voltage control (TSVC) rely heavily on manual action or mathematical optimization methods, which face challenges when addressing the ...

Step count thresholds for reducing the risk for type 2 diabetes (T2D) varied according to genetic susceptibility, with individuals at high polygenic risk requiring higher daily step counts to achieve ...

Abstract: Engineering drawings are crucial design documents communicating intricate project details across various engineering disciplines. As the industry shifts towards digital solutions, accurately ...

From daily news and career tips to monthly insights on AI, sustainability, software, and more—pick what matters and get it in your inbox. Explore The Most Powerful Tech Event in the World with ...